Bench-to-bedside review: Circulating microparticles - a new player in sepsis?

TitreBench-to-bedside review: Circulating microparticles - a new player in sepsis?
Type de publicationArticle de revue
AuteurMeziani, Ferhat, Delabranche, Xavier, Asfar, Pierre , Toti, Florence
EditeurBioMed Central
TypeArticle scientifique dans une revue à comité de lecture
Titre de la revueCritical Care
Mots-clésEmergency Medicine, Intensive / Critical Care Medicine
Résumé en anglais

In sepsis, inflammation and thrombosis are both the cause and the result of interactions between circulating (for example, leukocytes and platelets), endothelial and smooth muscle cells. Microparticles are proinflammatory and procoagulant fragments originating from plasma membrane generated after cellular activation and released in body fluids. In the vessel, they constitute a pool of bioactive effectors pulled from diverse cellular origins and may act as intercellular messengers. Microparticles expose phosphatidylserine, a procoagulant phospholipid made accessible after membrane remodelling, and tissue factor, the initiator of blood coagulation at the endothelial and leukocyte surface. They constitute a secretion pathway for IL-1β and up-regulate the proinflammatory response of target cells. Microparticles circulate at low levels in healthy individuals, but undergo phenotypic and quantitative changes that could play a pathophysiological role in inflammatory diseases. Microparticles may participate in the pathogenesis of sepsis through multiple ways. They are able to regulate vascular tone and are potent vascular proinflammatory and procoagulant mediators. Microparticles' abilities are of increasing interest in deciphering the mechanisms underlying the multiple organ dysfunction of septic shock.

URL de la notice
Lien vers le document